Skip to main content

Advertisement

Log in

Routine preoperative 123I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Functional imaging using 123I-meta-iodo-benzyl-guanetidine (MIBG) scintigraphy has alleged 100% specificity for phaeochromocytoma (PHAEO). Its benefit in patients with biochemical diagnosis of PHAEO is arguable when cross-sectional radiology can demonstrate the side–size of the adrenal tumours.

Materials and methods

This is a retrospective review of clinical notes of patients undergoing adrenalectomy for PHAEO in a University centre.

Results

Between January 2000 and December 2007, adrenalectomy for PHAEO was performed on 66 patients (28 M and 38 F, aged 24–82 years). Diagnosis was demonstrated by raised 24-h urine catecholamines (n = 14) or metanephrines (n = 52). The side and size of adrenal tumours were demonstrated on computed tomography (n = 58) and/or magnetic resonance imaging (n = 20) scans. MIBG scans were performed in 38 patients. Four of these patients were found to have non-adrenal pathology (haemangioblastomas, haemangioma, a bronchogenic cyst and an angiomyolipoma); hence, the positive predictive value of MIBG scan was 90%. In a further five patients, MIBG raised the suspicion of local metastatic disease but this was not confirmed on operative findings and no recurrence was detected in these patients during 6–92-month follow-up. This led to an overall rate of false-positive rate of 23%.

Conclusion

MIBG scintigraphy adds little to the routine preoperative management of patients with suspected PHAEO. Its use should be limited to the small minority of patients with negative cross-sectional imaging and those with recurrent or metastatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lumachi F et al (2006) Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study. Nucl Med Commun 27(7):583–587

    Article  PubMed  Google Scholar 

  2. Shapiro B et al (1985) Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26(6):576–585

    PubMed  CAS  Google Scholar 

  3. Van Der Horst-Schrivers AN et al (2006) Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas—experience and meta-analysis. Anticancer Res 26(2B):1599–1604

    Google Scholar 

  4. Mihai R, Sadler GP, Bridge H (2008) Adrenergic blockade with phenoxybenzamine and propranolol in a cohort of 60 patients undergoing surgery for phaeochromocytoma. Eur J Anaesthesiol 25(6):508–510

    Article  PubMed  CAS  Google Scholar 

  5. Burns C et al (1987) Adrenal hemangioblastoma in Von Hippel-Lindau disease as a cause of secondary erythrocytosis. Am J Med Sci 293(2):119–121

    Article  PubMed  CAS  Google Scholar 

  6. Horne T et al (1991) Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue. Clin Nucl Med 16(4):239–242

    Article  PubMed  CAS  Google Scholar 

  7. Sone H et al (1996) Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review. Horm Res 46(3):138–142

    Article  PubMed  CAS  Google Scholar 

  8. Letizia C et al (1998) False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan. J Endocrinol Invest 21(11):779–783

    PubMed  CAS  Google Scholar 

  9. Krubsack AJ et al (1988) Zona fasciculata cortical adenoma and adrenal medullary hyperplasia in MEN II patient: unique concurrent presentation. Clin Nucl Med 13(10):730–733

    Article  PubMed  CAS  Google Scholar 

  10. Rainis T, Ben-Haim S, Dickstein G (2000) False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma. J Clin Endocrinol Metab 85(1):5–7

    Article  PubMed  CAS  Google Scholar 

  11. Takasu N et al (2007) False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma. Intern Med 46(20):1717–1721

    Article  PubMed  Google Scholar 

  12. Frappaz D et al (1997) False positive MIBG scan. Med Pediatr Oncol 29(6):589–892

    Article  PubMed  CAS  Google Scholar 

  13. Granata C et al (2001) False positive MIBG scan due to accessory spleen. Med Pediatr Oncol 37(2):138–139

    Article  PubMed  CAS  Google Scholar 

  14. Sampol Bas C, Pena Viloria C (2005) Uptake of 123I-MIBG in a hepatic hemangioma in the scintigraphic study of an adrenal gland lesion. Rev Esp Med Nucl 24(3):191–194

    PubMed  CAS  Google Scholar 

  15. Ong YY et al (2002) The importance of renal localization with MIBG scintigraphy. Clin Nucl Med 27(7):479–482

    Article  PubMed  Google Scholar 

  16. Gallar P et al (1993) Renal failure as a cause of false-positive on metaiodobenzylguanidine (MIBG) scan. Nephrol Dial Transplant 8(5):481

    PubMed  CAS  Google Scholar 

Download references

Financial support

None

Conflict of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Radu Mihai.

Additional information

Best of Endocrine Surgery in Europe 2008.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mihai, R., Gleeson, F., Roskell, D. et al. Routine preoperative 123I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary. Langenbecks Arch Surg 393, 725–727 (2008). https://doi.org/10.1007/s00423-008-0387-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-008-0387-2

Keywords

Navigation